Artiva Biotherapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
ARTV chart
What traders are saying about $ARTV
Latest postsArtiva Biotherapeutics, Inc. news
- Sector Update: Healthcare Stocks Decline Late Afternoon
Yahoo Finance ·
- Artiva Biotherapeutics downgraded by Wedbush with a new price target
Quantisnow ·
- Why Is Artiva Biotherapeutics Stock (ARTV) Down 31% Today?
TipRanks ·
- Artiva Biotherapeutics Plunges Into Crisis Over Patient Deaths and Possible Liquidation
Yahoo Finance ·
- Why Is Artiva Biotherapeutics Stock Tumbling Today? - Artiva Biotherapeutics (NASDAQ:ARTV)
Benzinga ·
- Why Is Artiva Biotherapeutics Discontinuing AlloNK Development and Cutting 94% of Its Workforce?
investorshub.advfn.com ·
- Artiva to quit autoimmune cell therapy work, cut staff after patient deaths
biopharmadive.com ·
- TD Cowen downgrades Artiva Biotherapeutics stock rating to hold
Investing.com ·
- Artiva Biotherapeutics downgraded to Hold at Needham after discontinuing AlloNK
TipRanks ·
- Artiva Scraps Development Of Lead Drug Candidate After Patient Deaths — ARTV Stock Heads For Worst Session In Over 18 Months
stocktwits.com ·
- ARTV Stock Holds Support As Cash Runway Draws Trader Focus
StocksToTrade ·
- Form 8K Artiva Biotherapeutics Inc For: 27 October By Investing.com
Investing.com India ·
Artiva Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $0 | $251,000 | $33.5M |
| Net income | -$83.9M | -$65.4M | -$28.7M |
| Diluted EPS | $-3.43 | $-5.81 | $-35.78 |
| Total assets (year end) | $130.9M | $209.6M | $105.1M |
| Cash and equivalents (year end) | $26.7M | $40.2M | $53.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Artiva Biotherapeutics, Inc.
- Ticker
- ARTV (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1817241
Frequently asked questions
What exchange is Artiva Biotherapeutics, Inc. listed on?
Artiva Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol ARTV.
What industry is Artiva Biotherapeutics, Inc. in?
Artiva Biotherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Artiva Biotherapeutics, Inc. headquartered?
Artiva Biotherapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Artiva Biotherapeutics, Inc.'s fiscal year end?
Artiva Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Artiva Biotherapeutics, Inc. report?
Artiva Biotherapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.